Portfolio
The NeuroTechnology Partners Fund gives investor access to participate in the value created by the more than 300 physician leaders in the NTI network. These physicians identify, vet and support the development of innovative medical technologies and promising business models. The current NTI Partners Fund portfolio includes:
Neurotechnology to address the limitations of the human body. The world’s first minimally invasive brain computer interface.
Developing neurovascular therapies for venous stenosis.
Developing the Endoport Vacuum Assisted Collection (EVAC™) for subdural hematoma drainage
A patented new catheter platform for vascular access to obsolete the current design standard
